Researchers review muscular dystrophy therapies
05:38 EDT 22 Jun 2012 | Medical Xpress
Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published this week in Science..
Original Article: Researchers review muscular dystrophy therapies
More From BioPortfolio on "Researchers review muscular dystrophy therapies"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
